FDA 483 - Pine Pharmaceuticals, LLC - September 19, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pine Pharmaceuticals, LLC in Tonawanda, NY, from September 6-19, 2023, revealed significant deficiencies across multiple areas. The firm's quality control unit lacked proper authority and failed to adequately investigate product defects, batch failures, and complaints, including those related to particulate matter. Additionally, the inspection identified issues with aseptic processing, environmental control, facility cleanliness, and a failure to report compounded drugs to the FDA.
ID · 3c7b832f-d00c-40e1-9678-fd3f0822759f